Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

16 Nov 2012 07:00

RNS Number : 2676R
Gleeson(M J)Group PLC
16 November 2012
 



Friday 16 November 2012

 

 

M J GLEESON GROUP PLC

 

INTERIM MANAGEMENT STATEMENT

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2012 to 15 November 2012, in accordance with the UK Listing Authority's Disclosure and Transparency Rules.

 

Gleeson operates as the following divisions:

 

·; a housebuilder, mainly in the North of England, with a particular focus on low cost homes for local people;

 

·; a strategic land development business, mainly in the South of England, that enhances the value of land, principally held under option, through the planning process;

 

Gleeson Homes

 

Total sales, comprising reserved, contracted and completed homes, are up by 42% from a year ago.

 

Since the beginning of the period we have opened six new sites, two in each region. A total of 26 sites are currently open.

 

Prices for units being sold are in line with management's expectations at an average of £119,000. This is a decrease of £9,000 from the prior year due to a change in geographic mix. The proportion of units being sold on recently acquired higher margin sites has improved significantly since the prior year, with only 25% of total sales noted above from old, low margin sites, compared to 64% in the comparable period.

 

The housing market in the North of England remains challenging and weekly sales rates have on occasion fallen below expectations. Nonetheless, the division's very successful control of costs, coupled with the substantial increase in the number of new higher margin selling outlets, has meant that the overall level of sales achieved during the period will deliver a substantially improved level of profitability.

 

As previously reported, mortgage availability continues to remain restricted. However, we have seen a significant level of interest in the Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan. In addition, Gleeson Homes is one of the first developers to have secured a low interest loan for site specific development from the Government's Get Britain Building Fund.

 

Five sites have been purchased during the period, which have added 331 plots to the Group's land bank. The Group is currently in discussions regarding the acquisition of a further 13 sites, which, if purchased, will add 1,082 plots to the land bank, taking the total number of plots to in excess of 3,700.

 

Gleeson Strategic Land

 

During the period, Gleeson Strategic Land has sold two significant sites and continues to replenish the portfolio, entering three new agreements since 1 July 2012, comprising 170 acres and, potentially, 1,000 plots.

 

The volume housebuilders continue to display a strong appetite for green field residential land in the South of England and Gleeson Strategic Land is experiencing a high level of interest in the sites which it hopes to bring to the market in the remainder of the year.

 

Outlook

 

The Board is encouraged by the achievements of both Gleeson Homes and Gleeson Strategic Land in challenging circumstances and remains confident that they are laying the foundations of a strong and sustainable improvement in the Group's performance.

 

 

 

 

 

 

Enquiries:

 

M J Gleeson Group plc 01252 360 300

 

Jolyon Harrison Chief Executive Officer

Alan Martin Chief Financial Officer

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMMMVKDGZZM
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.